|
1
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pox CP: Controversies in colorectal cancer
screening. Digestion. 89:274–281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang YL, Zhang ZS, Wu BP and Zhou DY:
Early diagnosis for colorectal cancer in China. World J
Gastroenterol. 8:21–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
American Cancer Society, . What are the
survival rates for colorectal cancer by stage? http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-survival-ratesAccessed.
October 15–2015.
|
|
5
|
O'Connell JB, Maggard MA and Ko CY: Colon
cancer survival rates with the new American Joint Committee on
Cancer sixth edition staging. J Natl Cancer Inst. 96:1420–1425.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bijan MD and Azadeh S: An overview of
colorectal cancer survival rates and prognosis in Asia. World J
Gastrointest Oncol. 4:71–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takuji T, Mayu T, Takahiro T and Rikako I:
Biomarkers for Colorectal Cancer. Int J Mol Sci. 11:3209–3225.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP and Chen CZ: Micromanagers of
gene expression: The potentially widespread influence of metazoan
microRNAs. Nat Rev Genet. 5:396–400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sonja H and Damjan G: MicroRNAs as Novel
Biomarkers in Colorectal Cancer. Front Genet. 3:1802012.PubMed/NCBI
|
|
16
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iorio MV and Croce CM: MicroRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vega A Brunet, Pericay C, Moya I, Ferrer
A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A
and Saigí E: MicroRNA expression profile in stage III colorectal
cancer: Circulating miR-18a and miR-29a as promising biomarkers.
Oncol Rep. 30:320–326. 2013.PubMed/NCBI
|
|
22
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang L, Deng T, Li X, Liu H, Zhou H, Ma
J, Wu M, Zhou M, Shen S, Li X, et al: microRNA-141 is involved in a
nasopharyngeal carcinoma-related genes network. Carcinogenesis.
31:559–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahn YH, Yang Y, Gibbons DL, Creighton CJ,
Yang F, Wistuba II, Lin W, Thilaganathan N, Alvarez CA, Roybal J,
et al: Map2k4 functions as a tumor suppressor in lung
adenocarcinoma and inhibits tumor cell invasion by decreasing
peroxisome proliferator-activated receptor γ2 expression. Mol Cell
Biol. 31:4270–4285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Davis SJ, Choong DY, Ramakrishna M, Ryland
GL, Campbell IG and Gorringe KL: Analysis of the mitogen-activated
protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian
cancer. BMC Cancer. 11:1732011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He D, Miao H, Xu Y, Xiong L, Wang Y, Xiang
H, Zhang H and Zhang Z: MiR-371-5p facilitates pancreatic cancer
cell proliferation and decreases patient survival. PLoS One.
9:e1129302014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Krutzfeldt J, Rajewsky N, Braich R, Rajeev
KG, Tuschl T, Manoharan M and Stoffel M: Silencing of microRNAs in
vivo with ‘antagomirs’. Nature. 438:685–689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang B, Love TM, Call ME, Doench JG and
Novina CD: Recapitulation of short RNA-directed translational gene
silencing in vitro. Mol Cell. 22:553–560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wakiyama M, Takimoto K, Ohara O and
Yokoyama S: Let-7 microRNA-mediated mRNA deadenylation and
translational repression in a mammalian cell-free system. Genes
Dev. 21:1857–1862. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Djuranovic S, Nahvi A and Green R:
miRNA-mediated gene silencing by translational repression followed
by mRNA deadenylation and decay. Science. 336:237–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Olive V, Bennett MJ, Walker JC, Ma C,
Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ and He L: miR-19
is a key oncogenic component of mir-17–92. Genes Dev. 23:2839–2849.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee YS and Dutta A: The tumor suppressor
microRNA let-7 represses the HMGA2 oncogene. Genes Dev.
21:1025–1030. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vrba L, Jensen TJ, Garbe JC, Heimark RL,
Cress AE, Dickinson S, Stampfer MR and Futscher BW: Role for DNA
methylation in the regulation of miR-200c and miR-141 expression in
normal and cancer cells. PLoS One. 5:e86972010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Batista L, Bourachot B, Mateescu B, Reyal
F and Mechta-Grigoriou F: Regulation of miR-200c/141 expression by
intergenic DNA-looping and transcriptional read-through. Nat
Commun. 7:89592016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huidobro C, Urdinguio RG, Rodriguez RM,
Mangas C, Calvanese V, Martínez-Camblor P, Ferrero C, Parra-Blanco
A, Rodrigo L, Obaya AJ, et al: A DNA methylation signature
associated with aberrant promoter DNA hypermethylation of DNMT3B in
human colorectal cancer. Eur J Cancer. 48:2270–2281. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Felekkis K, Touvana E, Stefanou Ch and
Deltas C: microRNAs: A newly described class of encoded molecules
that play a role in health and disease. Hippokratia. 14:236–240.
2010.PubMed/NCBI
|
|
39
|
Hibio N, Hino K, Shimizu E, Nagata Y and
Ui-Tei K: Stability of miRNA 5′terminal and seed regions is
correlated with experimentally observed miRNA-mediated silencing
efficacy. Sci Rep. 2:9962012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Teng DH, Perry WL III, Hogan JK, Baumgard
M, Bell R, Berry S, Davis T, Frank D, Frye C, Hattier T, et al:
Human mitogen-activated protein kinase kinase 4 as a candidate
tumor suppressor. Cancer Res. 57:4177–4182. 1997.PubMed/NCBI
|
